- Home
- FKWL vs IGC Comparison
FKWL vs IGC Comparison
Compare FKWL & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FKWL
- IGC
- Stock Information
- Founded
- FKWL 1981
- IGC 2005
- Country
- FKWL United States
- IGC United States
- Employees
- FKWL N/A
- IGC N/A
- Industry
- FKWL Telecommunications Equipment
- IGC Biotechnology: Pharmaceutical Preparations
- Sector
- FKWL Utilities
- IGC Health Care
- Exchange
- FKWL Nasdaq
- IGC Nasdaq
- Market Cap
- FKWL 45.8M
- IGC 39.8M
- IPO Year
- FKWL 1996
- IGC N/A
- Fundamental
- Price
- FKWL $4.08
- IGC $0.42
- Analyst Decision
- FKWL
- IGC Strong Buy
- Analyst Count
- FKWL 0
- IGC 2
- Target Price
- FKWL N/A
- IGC $4.00
- AVG Volume (30 Days)
- FKWL 18.5K
- IGC 1.4M
- Earning Date
- FKWL 09-29-2025
- IGC 08-14-2025
- Dividend Yield
- FKWL N/A
- IGC N/A
- EPS Growth
- FKWL N/A
- IGC N/A
- EPS
- FKWL N/A
- IGC N/A
- Revenue
- FKWL $45,276,495.00
- IGC $1,327,000.00
- Revenue This Year
- FKWL N/A
- IGC $15.26
- Revenue Next Year
- FKWL N/A
- IGC $3.41
- P/E Ratio
- FKWL N/A
- IGC N/A
- Revenue Growth
- FKWL 8.62
- IGC 24.95
- 52 Week Low
- FKWL $3.67
- IGC $0.25
- 52 Week High
- FKWL $7.45
- IGC $0.50
- Technical
- Relative Strength Index (RSI)
- FKWL 48.46
- IGC 56.28
- Support Level
- FKWL $4.01
- IGC $0.39
- Resistance Level
- FKWL $4.62
- IGC $0.47
- Average True Range (ATR)
- FKWL 0.16
- IGC 0.04
- MACD
- FKWL -0.02
- IGC 0.00
- Stochastic Oscillator
- FKWL 16.39
- IGC 46.67
About FKWL Franklin Wireless Corp.
Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.
About IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.